Search
Searching with a thematic focus on HIV and AIDS in South Africa
Showing 151-160 of 223 results
Pages
- Document
Budgeting for HIV/AIDS in South Africa
Institute for Democracy in South Africa, 2003This report from IDASA's Budget Information Service analyses budget allocations and funding flows from the national fiscus for HIV/AIDS interventions. It investigates the best way to deliver funds to the provinces of South Africa to tackle HIV/AIDS.DocumentPaving the path: preparing for microbicide introduction
Engender Health, 2004This Engender Health report details the findings of a study which examined the issues likely to influence microbicide introduction at three levels: community, health service and policy. The report identifies critical issues which need to be addressed to allow for successful microbicide introduction strategies.DocumentThe role of education in promoting young people’s sexual and reproductive health
Centre for Sexual Health Research, Faculty of Social Sciences, University of Southampton, 2002This document outlines discussions from the Expert meeting for the Safe Passages to Adulthood programme, where researchers, practitioners and policy makers explored the potential of education to protect against HIV/AIDS, as well as the possible changes needed to enable the education system to respond more adequately.DocumentUNAIDS 2004 Report on the global AIDS epidemic
Joint United Nations Programme on HIV/AIDS, 2004This report warns that the number of people living with HIV, the virus that causes AIDS, has risen in every region of the world during 2003 and last year five million people became newly infected with HIV - more people than any previous year.The report highlights the latest global trends and, for the first time, features revised HIV prevalence rates for previous years, allowing for a better undDocumentPatents, access to medicines and the role of non-governmental organisations
Médecins Sans Frontières, 2004This Médecins Sans Frontières (MSF) paper looks at how patents adversely affect access to affordable medicines. Although effective medicine is available to treat many global diseases, one-third of the world’s population lacks access to these basic, but expensive drugs as a result of patent rights.Document“Hulle kan nie hulle hormone intoom hou nie”: a study on gender, adolescents and sexual behaviour in relation to HIV in South Africa
Centre for International Development Issues, University of Nijmegen, 2002This paper from the Centre for International Development Issues presents the results of research conducted among young people in South Africa, aiming to gain a better understanding of the sexual context of adolescents in the country. It looks at the question of how gender constructions influence risk-related sexual behaviour among adolescents.DocumentYoung people, HIV / AIDS, and intervention: barriers and gateways to behaviour change
Development Studies Network, 2000This paper reports from a 1999 study that explored sexual dynamics and decision making among young people between the ages of 11 and 24 years in KwaZulu/Natal Province. Two aspects of youths’ sexual behaviour – condom use and abstinence – are discussed.DocumentThe impact of HIV/AIDS on the health sector: national survey of health personnel, ambulatory and hospitalised patients and health facilities
Human Sciences Research Council, South Africa, 2003This report for the South African Department of Health explores the impact of HIV/AIDS on the South African health system, with an aim to assist policy and programming decisions in response to the epidemic.Document25 years of essential medicines progress
Essential Drugs and Medicine Policy, WHO, 2003The historic first meeting of the World Health Organization (WHO) Expert Committee on the Selection of Essential Drugs took place in Geneva in 1977. Today, more than 150 countries have adopted the concept and developed their own national lists of essential medicines.This special issue of the Essential Drugs Monitor, produced by the WHO, celebrates 25 years of the essential medicines concept.DocumentDrugs for HIV in South Africa
The Lancet Infectious Diseases, 2004This short article presents the main features of the a South African major plan to provide antiretroviral (ARV) drugs to hundreds of thousands of HIV-infected patients.Findings include:about 50 000 people could receive drug treatment in 2004, rising to as many as 1-4 million by 2009the total budget will rise from US$44 million in 2005 to $666 million in 200950 service points arePages
